1-5 of 5
Matteo Pelosini, M.D.
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Aggressive Non Hodgkin lymphoma'patients Treated by High Dose Chemotherapy and Immunotherapy Has a Lower Relapse Rate: Results of a Computer Science Analysis.

Matteo Pelosini, M.D., Flavio Baronti, Francesco Caracciolo, Sara Galimberti, Edoardo Benedetti, Federico Papineschi, Enrico Orciuolo, Gabriele Buda, Antonina Starita, Mario Petrini, MD
Journal: Blood
Blood (2009) 114 (22): 4772.
https://doi.org/10.1182/blood.V114.22.4772.4772
Published: 2009
Journal Articles

Optimizing Follow up Schedule for Non Hodgkin Lymphoma' Patients by Multi-Objective Analysis.

Matteo Pelosini, M.D., Flavio Baronti, Francesco Caracciolo, Sara Galimberti, Edoardo Benedetti, Federico Papineschi, Enrico Orciuolo, Gabriele Buda, Antonina Starita, Mario Petrini, MD
Journal: Blood
Blood (2009) 114 (22): 3945.
https://doi.org/10.1182/blood.V114.22.3945.3945
Published: 2009
Journal Articles

The Role of Imaging in Relapse Detection During Follow up: a Fifteen-Year Single Center Experience.

Matteo Pelosini, M.D., Francesco Caracciolo, Sara Galimberti, Edoardo Benedetti, Federico Papineschi, Enrico Orciuolo, Gabriele Buda, Mario Petrini, MD
Journal: Blood
Blood (2009) 114 (22): 5007.
https://doi.org/10.1182/blood.V114.22.5007.5007
Published: 2009
Journal Articles

Reduced-Intensity Regimens for Allogeneic Stem Cell Transplantation Improve the Outcome in Advanced Multiple Myeloma

Suzanne M. Cole, MD, Rima Saliba, Matteo Pelosini, M.D., Floralyn L Mendoza, Donna Weber, MD, Michael Wang, MD, Sheeba Thomas, MD, Robert Z. Orlowski, MD, PhD, Jatin Shah, MD, Amin Alousi, MD, Chitra Hosing, MD, Uday Popat, MD, Partow Kebriaei, MD, Paolo Anderlini, MD, Issa F. Khouri, Richard Champlin, MD, Sergio Giralt, MD, Muzaffar H. Qazilbash, MD
Journal: Blood
Blood (2008) 112 (11): 3298.
https://doi.org/10.1182/blood.V112.11.3298.3298
Published: 2008
Journal Articles

A Randomized Phase II Trial of High-Dose Melphalan, Ascorbic Acid and Arsenic Trioxide with or without Bortezomib in Multiple Myeloma

Muzaffar H. Qazilbash, Rima M. Saliba, Matteo Pelosini, M.D., Chitra M Hosing, Floralyn L Mendoza, Eric Han, Michael Wang, MD, Donna M. Weber, Amin M. Alousi, Paolo Anderlini, Partow Kebriaei, Issa F. Khouri, Uday R Popat, Marcos De Lima, Robert Z. Orlowski, MD, PhD, Richard E. Champlin, Sergio A. Giralt
Journal: Blood
Blood (2008) 112 (11): 3320.
https://doi.org/10.1182/blood.V112.11.3320.3320
Published: 2008